PharmAust

(ASX) PAA

Current PriceN/A

Market CapN/A

Since IPO (2001)-99%

5 Year-18%

1 Year-46%

1 Month-8%

PharmAust Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$3.68M

Net Income (TTM)

$13.90M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

PAA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About PharmAust

Industry

Pharmaceuticals

Sector

Health Care

CEO

Michael Thurn, PhD

Website

www.pharmaust.com

Headquarters

Bentley, WA 6102, AU

PAA Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-3%

Return on Capital

-7%

Return on Assets

-4%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$1.64K

Operating Income

$6.66M

EBITDA

$9.45M

Operating Cash Flow

$5.17M

Capital Expenditure

$3.00

Free Cash Flow

$5.17M

Cash & ST Invst.

$9.72M

Total Debt

$0.00

PharmAust Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2024YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$1.64K

-195.4%

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$7.30M

-1417.8%

EBITDA

$7.29M

-2426.0%

Quarterly Fundamentals

Name

Q4 2024YOY CHG

Net Cash

$9.72M

+839.2%

Accounts Receivable

$146.01K

-28.5%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

-3.81%

N/A

Return on Invested Capital

-6.54%

N/A

Free Cash Flow

$5.12M

-1498.1%

Operating Cash Flow

$5.12M

-1189.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

LV1.AXLive Verdure Ltd

LV1.AXLive Verdure Ltd$0.92+0.00%

BNO.AXBionomics Limited

BNO.AXBionomics Limited$0.01-10.00%

MDC.AXMedlab Clinical Limited

MDC.AXMedlab Clinical Limited$6.60+0.00%

HXL.AXHexima Limited

HXL.AXHexima Limited$0.01+0.00%

RGS.AXRegeneus Ltd

RGS.AXRegeneus Ltd$0.01+33.33%

RSH.AXRespiri Limited

RSH.AXRespiri Limited$0.03+0.00%

LCT.AXLiving Cell Technologies Limited

LCT.AXLiving Cell Technologies Limited$0.01+7.14%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.28-0.02%

NVTSNavitas Semiconductor

NVTSNavitas Semiconductor$22.06+0.21%

ODYSOdysight.ai

ODYSOdysight.ai$6.90+0.55%

DGXXDigi Power X

DGXXDigi Power X$7.84+0.18%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.38-0.00%

CRCLCircle Internet Group

CRCLCircle Internet Group$122.45+0.08%

MARAMara Holdings

MARAMara Holdings$13.46+0.04%

Questions About PAA

What is the current price of PharmAust?

PharmAust is trading at N/A per share.

What is the 52-week range for PharmAust?

Over the past 52 weeks, PharmAust has traded between N/A and N/A.

How much debt does PharmAust have?

As of the most recent reporting period, PharmAust reported total debt of N/A.

How much cash does PharmAust have on hand?

PharmAust reported $4.16M in cash and cash equivalents in its most recent financial results.

What is PharmAust’s dividend yield?

PharmAust does not currently have a dividend yield.

PharmAust

PharmAust Financials at a Glance

PAA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About PharmAust

PAA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

PharmAust Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PAA

What is the current price of PharmAust?

What is the 52-week range for PharmAust?

How much debt does PharmAust have?

How much cash does PharmAust have on hand?

What is PharmAust’s dividend yield?

Premium Investing Services